Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo
Osteosarcoma (OS) is a malignant primary bone tumor with high metastatic rate. C-X-C motif chemokine ligand 6 (CXCL6) and its receptor C-X-C motif chemokine receptor 1/2 (CXCR1/2) have been found to participate in the process of carcinogenesis. In this study, we evaluated the role of CXCL6/CXCR1/2 a...
Main Authors: | Guangchen Liu, Liping An, Hongmei Zhang, Peige Du, Yu Sheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00307/full |
Similar Items
-
Caulis Spatholobi extracts inhibit osteosarcoma growth and metastasis through suppression of CXCR4/PI3K/AKT signaling
by: Yang Jiang, et al.
Published: (2023-12-01) -
CXCL1/CXCR2 Paracrine Axis Contributes to Lung Metastasis in Osteosarcoma
by: Chia-Chia Chao, et al.
Published: (2020-02-01) -
CXCL13/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma
by: Ju-Fang Liu, et al.
Published: (2020-08-01) -
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies
by: Tripti Khare, et al.
Published: (2021-07-01) -
CXCL14 antagonizes the CXCL12-CXCR4 signaling axis
by: Hara Takahiko, et al.
Published: (2014-05-01)